Another one bites the dust. Thanks for the find Des. My only hope is topical fin with minimal sides. Clan, that's what we should be waiting for. Start saving for a good HT.
Histogen's FINAL Phase I/IIa Results (2013)
Collapse
X
-
I contacted HISTOGEN via e-mail, and here's what I got from them:
"Thank you for your interest and message. In the Phase I / II clinical trial of HSC, Which has recently passed the final timepoints, a Significant increase in vellus hair count was seen for the first time. this was in addition to improvement across efficacy measures, including total and terminal hair counts. this supports the hypothesis that the HSC treatment rescues dormant follicles, in addition to converting vellus to terminal hairs and becoming the number of hairs per follicle. However, there is much more to be learned in this area before mechanisms can be pointed to with any level of certainty.
While the Phase I / II has passed all timepoints, data from that trial is still being analyzed. I anticipate Histogen HSC will have updates to share in the next couple of months. The Company is not currently releasing any estimated timeframes for market introduction of HSC, however we can say that at least one additional clinical trial will be required in any geographic region where the HSC will be brought to market ..
I look forward to sharing HSC updates soon. Please do also check back to our website periodically for the latest news Histogen. "
I got this 10th May!Comment
-
I contacted HISTOGEN via e-mail, and here's what I got from them:
"Thank you for your interest and message. In the Phase I / II clinical trial of HSC, Which has recently passed the final timepoints, a Significant increase in vellus hair count was seen for the first time. this was in addition to improvement across efficacy measures, including total and terminal hair counts. this supports the hypothesis that the HSC treatment rescues dormant follicles, in addition to converting vellus to terminal hairs and becoming the number of hairs per follicle. However, there is much more to be learned in this area before mechanisms can be pointed to with any level of certainty.
While the Phase I / II has passed all timepoints, data from that trial is still being analyzed. I anticipate Histogen HSC will have updates to share in the next couple of months. The Company is not currently releasing any estimated timeframes for market introduction of HSC, however we can say that at least one additional clinical trial will be required in any geographic region where the HSC will be brought to market ..
I look forward to sharing HSC updates soon. Please do also check back to our website periodically for the latest news Histogen. "
I got this 10th May!Comment
-
I got this three weeks ago! Finally, the output from will be published in the "NEWS" on the official website HISTOGEN. Now, there are currently no news! http://www.histogen.com/aboutus/news.htmComment
-
I got this three weeks ago! Finally, the output from will be published in the "NEWS" on the official website HISTOGEN. Now, there are currently no news! http://www.histogen.com/aboutus/news.htmComment
-
Hehe. I always try to remain positive. But man ... these data suck. I hadn't expected the effects to wear off over time, let alone so damn quickly !! And they can't really up the doses much because of the health risk (adverse effects on hemoglobin count). So to me it seems we can scratch Histogen as one of our future treatments. Or am I missing something ?Comment
-
Hehe. I always try to remain positive. But man ... these data suck. I hadn't expected the effects to wear off over time, let alone so damn quickly !! And they can't really up the doses much because of the health risk (adverse effects on hemoglobin count). So to me it seems we can scratch Histogen as one of our future treatments. Or am I missing something ?Comment
Comment